Financial commitments in research


In fiscal year 2009–2010, Emory’s Woodruff Health Sciences Center (WHSC) was awarded $500.7 million in research funding, bringing Emory University’s total for the year to $535.1 million, an increase of 10.5% over the previous year.

These awards include $15.5 million from NIH to the Emory Vaccine Center to improve vaccine effectiveness, $8.1 million from the Gates Foundation to the nursing school to improve maternal and newborn survival in rural Ethiopia, $8 million from NIH to renew Emory’s designation as an Alzheimer’s Disease Research Center (one of only 30 in the country), and $5.6 million to Emory and University of Georgia to establish one of six NIH core centers on drug abuse to understand how to prevent such risky behavior. There are many others as well.

To obtain such awards, Emory must be prepared to make considerable financial investments of its own to pay the overhead costs to conduct this research. Last year, for example, the total cash lost for unreimbursed overhead costs for research in the WHSC was approximately $103.6 million. Investment in such effort has a track record of yielding important dividends in discovery and also sparking economic growth. While well worth the cost, research investment nonetheless consumes a significant portion of the WHSC overall budget capacity.

Table of Contents

emory ce cover